Price
Target price
€1.40
€1.40
-1.410%
-0.02
-1.410%
-
12.12.25 / Stuttgart Stock Exchange
WKN: A2PP89 / Name: Lineage Cell Therapeutics Inc. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Lineage Cell Therapeutics Inc. is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for Lineage Cell Therapeutics Inc.
sharewise wants to provide you with the best news and tools for Lineage Cell Therapeutics Inc., so we directly link to the best financial data sources.
Financials
News
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious neurological and
